Stock Earnings Truist’s latest rating for PVLA stock In a filing, Palvella Therapeutics Inc revealed its Director JENKINS GEORGE M acquired Company’s shares for reported $50472.0 on Apr
Analysts Viewpoint Palvella Therapeutics Inc (PVLA) Becoming More Attractive for Investors Palvella Therapeutics Inc’s recent filing unveils that its Director JENKINS GEORGE M acquired Company’s shares for reported $50472.0 on Apr